Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Matrix Service
MTRX
$330M
| $4.76M | ﹤0.01% |
455,461
-81,863
| -15% | -$878K |
|
2402
Accel Entertainment
ACEL
$1B
| $4.72M | ﹤0.01% |
388,885
+10,986
| +3% | +$126K |
|
2403
Winmark
WINA
$1.26B
| $4.72M | ﹤0.01% |
21,933
+318
| +1% | +$65.4K |
|
|
NWLI
2404
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $4.71M | ﹤0.01% |
22,371
-760
| -3% | -$165K |
|
2405
Great Southern Bancorp
GSBC
$877M
| $4.7M | ﹤0.01% |
85,814
+2,902
| +4% | +$153K |
|
2406
Crinetics Pharmaceuticals
CRNX
$8.96B
| $4.7M | ﹤0.01% |
223,247
+27,326
| +14% | +$572K |
|
2407
PDF Solutions
PDFS
$2.19B
| $4.7M | ﹤0.01% |
203,902
+1,948
| +1% | +$40.1K |
|
|
MYOV
2408
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.69M | ﹤0.01% |
208,822
+16,007
| +8% | +$351K |
|
2409
First Mid Bancshares
FMBH
$1.38B
| $4.68M | ﹤0.01% |
114,080
+5,333
| +5% | +$214K |
|
2410
Arcutis Biotherapeutics
ARQT
$3.3B
| $4.68M | ﹤0.01% |
195,837
+2,455
| +1% | +$56K |
|
2411
Mission Produce
AVO
$1.13B
| $4.66M | ﹤0.01% |
253,742
+136,314
| +116% | +$2.68M |
|
|
RDUS
2412
DELISTED
Radius Health, Inc.
RDUS
| $4.66M | ﹤0.01% |
375,157
+2,237
| +0.6% | +$32.2K |
|
|
PETQ
2413
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.65M | ﹤0.01% |
186,270
+14,507
| +8% | +$437K |
|
2414
Angi Inc
ANGI
$176M
| $4.61M | ﹤0.01% |
37,367
-2,033
| -5% | -$234K |
|
2415
Universal Insurance Holdings
UVE
$1.18B
| $4.6M | ﹤0.01% |
352,791
-71,918
| -17% | -$981K |
|
2416
Duolingo
DUOL
$6.3B
| $4.6M | ﹤0.01% |
+27,645
| New | +$4.2M |
|
2417
Oric Pharmaceuticals
ORIC
$1.42B
| $4.59M | ﹤0.01% |
219,655
+88,840
| +68% | +$1.8M |
|
2418
OneSpan
OSPN
$609M
| $4.58M | ﹤0.01% |
243,982
+5,519
| +2% | +$117K |
|
2419
GeneDx Holdings
WGS
$2.46B
| $4.58M | ﹤0.01% |
+18,282
| New | +$6.28M |
|
2420
Ecopetrol
EC
$34.9B
| $4.58M | ﹤0.01% |
318,777
+6,760
| +2% | +$91.8K |
|
2421
Core & Main
CNM
$8.62B
| $4.57M | ﹤0.01% |
+174,300
| New | +$4.64M |
|
|
LAND
2422
Gladstone Land Corp
LAND
$353M
| $4.56M | ﹤0.01% |
200,397
+25,748
| +15% | +$600K |
|
|
MRSN
2423
DELISTED
Mersana Therapeutics
MRSN
| $4.55M | ﹤0.01% |
19,292
+2,793
| +17% | +$816K |
|
2424
Gulfport Energy Corp
GPOR
$3B
| $4.55M | ﹤0.01% |
+55,314
| New | +$3.85M |
|
2425
DHT Holdings
DHT
$3.01B
| $4.53M | ﹤0.01% |
693,626
+163,825
| +31% | +$949K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.